Biomotion Sciences Ordinary Shares (SLXN NASDAQ) stock market data APIs
$0.476
-0.04(-8.4%)
as of May 21, 2026
Try our APIs with
free plan!
Biomotion Sciences Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Prev. Close
0.476
Open
0.4388
High
0.522
Low
0.4371
52 wk Range
0.231-22.36
Market Cap
2 159 K
Shares Outstanding
4 075 K
EPS
-0.85
Beta
-0.289
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Biomotion Sciences Ordinary Shares data using free add-ons & libraries
Get Biomotion Sciences Ordinary Shares Fundamental Data
Biomotion Sciences Ordinary Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -11 618 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Biomotion Sciences Ordinary Shares Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -1.29
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Biomotion Sciences Ordinary Shares News
New
SLXN On Track, IMVT Hits New High, CTEV Eyes Blockbuster Revenue, Big Day Ahead For BDTX
(RTTNews) - In today's gainers' list, we cover HCW Biologics, its upcoming catalysts and going concern risks; Silexion's development progress of its lead drug candidate SIL204; Immunovant's encouragin...
Silexion Therapeutics Posts Wider Q1 Loss, Advances SIL204 Into Phase 2/3 Trials; Stock Up
(RTTNews) - Silexion Therapeutics Corp. (SLXN), a clinical-stage company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, reported first-quarter 2026 financial results and outline...
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer Clinical Trial Application subsequently submitted to Germany ...
Silexion Therapeutics prices new warrants exercise deal at $0.50 to raise $1M
* Silexion Therapeutics (SLXN [https://seekingalpha.com/symbol/SLXN]) announced on Friday that it has signed an agreement for the immediate exercise of around 2M outstanding warrants at a reduced pr...
Get Biomotion Sciences Ordinary Shares fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
